
3 Billion Pairs helps researchers and clinicians link genetic data to traits and behaviors to accelerate precision medicine research. The company aggregates DNA data with sociodemographic, sentiment-analysis, and quantified-self third-party APIs and applies machine learning to create searchable, analyzable datasets. It operates as a biotechnology research platform / B2B SaaS serving pharmaceutical and research customers and integrates via APIs and data pipelines. The offering targets precision medicine and drug-research use cases across pharma and academic markets.

3 Billion Pairs helps researchers and clinicians link genetic data to traits and behaviors to accelerate precision medicine research. The company aggregates DNA data with sociodemographic, sentiment-analysis, and quantified-self third-party APIs and applies machine learning to create searchable, analyzable datasets. It operates as a biotechnology research platform / B2B SaaS serving pharmaceutical and research customers and integrates via APIs and data pipelines. The offering targets precision medicine and drug-research use cases across pharma and academic markets.
What they do: ML research platform linking DNA with sociodemographic and third‑party API data for precision medicine
Founded: 2021 (London)
Stage / funding: Pre‑Seed (Jul 2021, lead: Systema)
Founder / key role: Stephan Tual (founder); David Tabizel (chairman)
Precision medicine and drug‑research (linking genomic data with behavioral and sociodemographic signals).
2021
Biotechnology